ANXA3 and nonpapillary renal cell carcinoma: These observations collectively suggest that the 36 kDa isoform of AnxA3 might exert a negative influence on the response to adipogenic treatment, implying its potential role as a regulator that curtails lipid storage in ccRCC cells [50].